Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2023-04-16 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
大信会计师事务所关于惠州市锦好医疗科技股份有限公司2022年年度募集资金存放与使用情况审核报告
Regulatory Filings
2023-04-16 Chinese
关于变更部分募投项目实际用途的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding changes in the actual use of some of the raised investment projects. It details the original and adjusted investment amounts, reasons for the changes, and the decision-making process including board and supervisory approvals. The document includes financial figures related to the use of raised funds but does not present a comprehensive financial report or detailed financial statements. It is a regulatory announcement about the change in use of funds raised from a previous capital raising event. The document length is 3975 characters, which is relatively short and focused on a specific capital use update. This fits best under the category of Capital/Financing Update (CAP), as it concerns the use and adjustment of capital raised through stock issuance and the company's investment projects. It is not an annual or interim report, audit report, or earnings release, nor is it a simple report publication announcement. Therefore, the classification is CAP with high confidence.
2023-04-16 Chinese
关于召开2022年年度股东大会通知公告(提供网络投票)
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 Annual General Meeting (AGM) of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed, and procedural information for shareholders. It references the 2022 Annual Report and other reports but does not contain the reports themselves. The document is under 5,000 characters and serves as an announcement for the AGM, not the report or results of the meeting. Therefore, it fits the category of AGM Information (AGM-R).
2023-04-16 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" for the year 2022. It contains detailed financial data, business overview, shareholder information, and audit opinions. The presence of an audit report with an unqualified opinion from a CPA firm is mentioned, which is typical in annual reports. The document length is 5585 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. The content includes comprehensive financial figures, business descriptions, shareholder structure, and management assurances, all characteristic of an Annual Report (10-K equivalent). Therefore, this document should be classified as an Annual Report (10-K). FY 2022
2023-04-16 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as an "年度报告 2022" which translates to "Annual Report 2022". It contains detailed sections typical of an annual report, including company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and management details, industry information, corporate governance, internal control, and financial accounting reports. The document includes comprehensive financial data such as income, profit, assets, liabilities, and quarterly financial data, as well as management's discussion of business operations and risks. It also mentions an unqualified audit opinion from a certified public accounting firm. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-16 Chinese
独立董事关于第二届董事会第二十四次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several proposals discussed at a board meeting, including the 2022 annual equity distribution plan, foreign exchange hedging transactions, and changes in the use of some fundraising projects. It references the board meeting held on April 13, 2023, and the proposals to be submitted to the 2022 annual shareholders' meeting. The content is about board opinions and approvals on corporate governance matters rather than a full financial report or announcement of voting results. It is not a full annual report, earnings release, or proxy solicitation. The document fits best under Board/Management Information (MANG) as it relates to board opinions and governance matters discussed in a board meeting.
2023-04-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.